Oncogene-induced basement membrane invasiveness in human mammary epithelial cells

[1]  T. Tsuruo,et al.  Serum and plasma M(r) 92,000 progelatinase levels correlate with spontaneous metastasis of rat 13762NF mammary adenocarcinoma. , 1993, Cancer research.

[2]  D. Miles,et al.  Activity of type IV collagenases in benign and malignant breast disease. , 1993, British Journal of Cancer.

[3]  M. Takeichi,et al.  Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. , 1993, Cancer research.

[4]  A. Howell,et al.  Expression of activated gelatinase in human invasive breast carcinoma , 1993, Clinical & Experimental Metastasis.

[5]  G. Nicolson,et al.  Mechanisms of c-erbB2/neu oncogene-induced metastasis and repression of metastatic properties by adenovirus 5 E1A gene products. , 1992, Oncogene.

[6]  Robert Clarke,et al.  Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines , 1992, Journal of cellular physiology.

[7]  R. Dickson,et al.  Regulation of basement membrane invasiveness in human breast cance model systems , 1991, Molecular and Cellular Endocrinology.

[8]  E. Gelmann,et al.  Cell adhesion molecule uvomorulin expression in human breast cancer cell lines: relationship to morphology and invasive capacities. , 1991, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[9]  M. Kraus,et al.  Oncogenic potential of erbB-2 in human mammary epithelial cells. , 1991, Oncogene.

[10]  L. Liotta,et al.  Laminin receptors, collagenase IV and prognosis in node‐negative breast cancers , 1991, International journal of cancer.

[11]  J. Bartek,et al.  Efficient immortalization of luminal epithelial cells from human mammary gland by introduction of simian virus 40 large tumor antigen with a recombinant retrovirus. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[12]  Z. Werb,et al.  92-kD type IV collagenase mediates invasion of human cytotrophoblasts , 1991, The Journal of cell biology.

[13]  J. Thiery,et al.  Secreted or nonsecreted forms of acidic fibroblast growth factor produced by transfected epithelial cells influence cell morphology, motility, and invasive potential. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[14]  U. Thorgeirsson,et al.  Ras levels and metalloproteinase activity in normal versus neoplastic rat mammary tissues , 1991, Clinical & Experimental Metastasis.

[15]  L. Liotta,et al.  Augmentation of type IV collagenase, laminin receptor, and Ki67 proliferation antigen associated with human colon, gastric, and breast carcinoma progression. , 1991, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

[16]  L. Liotta,et al.  Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation , 1991, Cell.

[17]  W. Stetler-Stevenson.  Type IV collagenases in tumor invasion and metastasis , 1990, Cancer and Metastasis Reviews.

[18]  J. Jouanneau,et al.  Expression of transfected transforming growth factor alpha induces a motile fibroblast-like phenotype with extracellular matrix-degrading potential in a rat bladder carcinoma cell line. , 1990, Cell regulation.

[19]  G. Merlo,et al.  Stromal influences on transformation of human mammary epithelial cells overexpressing c‐myc and SV40T , 1990, Journal of cellular physiology.

[20]  K. Weber,et al.  Vimentin is preferentially expressed in high-grade ductal and medullary, but not in lobular breast carcinomas. , 1990, The American journal of pathology.

[21]  L. Liotta,et al.  Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. , 1990, Cancer research.

[22]  W. Fiers,et al.  Hormone sensitivity in vitro and in vivo of v‐ras‐transfected mcf‐7 cell derivatives , 1990, International journal of cancer.

[23]  S. Albelda,et al.  Integrins and other cell adhesion molecules , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[24]  L. Liotta,et al.  Immunohistochemical distribution of type IV collagenase in normal, benign, and malignant breast tissue. , 1990, The American journal of pathology.

[25]  J. Thiery,et al.  Epithelial cell adhesion mechanisms , 1989, The Journal of Membrane Biology.

[26]  E. Lane,et al.  Keratin expression in human mammary epithelial cells cultured from normal and malignant tissue: relation to in vivo phenotypes and influence of medium. , 1989, Journal of cell science.

[27]  A. Eisen,et al.  SV40-transformed human lung fibroblasts secrete a 92-kDa type IV collagenase which is identical to that secreted by normal human macrophages. , 1989, The Journal of biological chemistry.

[28]  W. Kueng,et al.  Quantification of cells cultured on 96-well plates. , 1989, Analytical Biochemistry.

[29]  C. Harris,et al.  Expression of type IV collagenase and procollagen genes and its correlation with the tumorigenic, invasive, and metastatic abilities of oncogene-transformed human bronchial epithelial cells. , 1989, Cancer research.

[30]  E. Gelmann,et al.  Vimentin rather than keratin expression in some hormone-independent breast cancer cell lines and in oncogene-transformed mammary epithelial cells. , 1989, Cancer research.

[31]  A S Leong,et al.  Vimentin—a new prognostic parameter in breast carcinoma? , 1989, The Journal of pathology.

[32]  C. Harris,et al.  Invasive and metastatic potential of a v-Ha-ras-transformed human bronchial epithelial cell line. , 1989, Journal of the National Cancer Institute.

[33]  A. Leong,et al.  Co‐expression of cytokeratin and vimentin intermediate filament proteins in benign and neoplastic breast epithelium , 1989, The Journal of pathology.

[34]  S. Yamagata,et al.  Gelatinases of murine metastatic tumor cells. , 1989, Biochemical and biophysical research communications.

[35]  S. Yagel,et al.  Normal nonmetastatic human trophoblast cells share in vitro invasive properties of malignant cells , 1988, Journal of cellular physiology.

[36]  F. McCormick,et al.  Transformation of human mammary epithelial cells by oncogenic retroviruses. , 1988, Cancer research.

[37]  J. Seltzer,et al.  H-ras oncogene-transformed human bronchial epithelial cells (TBE-1) secrete a single metalloprotease capable of degrading basement membrane collagen. , 1988, The Journal of biological chemistry.

[38]  F. Rilke,et al.  Vimentin and p53 expression on epidermal growth factor receptor-positive, oestrogen receptor-negative breast carcinomas. , 1988, British Journal of Cancer.

[39]  L. Liotta,et al.  Role of laminin receptor in tumor cell migration. , 1987, Cancer research.

[40]  Y Iwamoto,et al.  A rapid in vitro assay for quantitating the invasive potential of tumor cells. , 1987, Cancer research.

[41]  H. Kleinman,et al.  17 beta-estradiol regulates and v-Ha-ras transfection constitutively enhances MCF7 breast cancer cell interactions with basement membrane. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[42]  L. Liotta,et al.  Altered levels of laminin receptor mRNA in various human carcinoma cells that have different abilities to bind laminin. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[43]  G. Laurie,et al.  Basement membrane complexes with biological activity. , 1986, Biochemistry.

[44]  R. Weinberg,et al.  The action of oncogenes in the cytoplasm and nucleus. , 1985, Science.

[45]  L. Liotta,et al.  Harvey ras induction of metastatic potential depends upon oncogene activation and the type of recipient cell. , 1985, The American journal of pathology.

[46]  Martha R. Stampfer,et al.  Isolation and growth of human mammary epithelial cells , 1985 .

[47]  L. Liotta,et al.  NIH/3T3 cells transfected with human tumor DNA containing activated ras oncogenes express the metastatic phenotype in nude mice , 1985, Molecular and cellular biology.

[48]  D. Vestweber,et al.  Rabbit antiserum against a purified surface glycoprotein decompacts mouse preimplantation embryos and reacts with specific adult tissues. , 1984, Experimental cell research.

[49]  L. Liotta,et al.  Isolation and characterization of type IV procollagen, laminin, and heparan sulfate proteoglycan from the EHS sarcoma. , 1982, Biochemistry.

[50]  L. Liotta,et al.  Effect of natural protease inhibitors and a chemoattractant on tumor cell invasion in vitro. , 1982, Journal of the National Cancer Institute.

[51]  M. Stampfer,et al.  Growth of normal human mammary cells in culture , 1980, In Vitro.

[52]  E. Dowdle,et al.  Electrophoretic analysis of plasminogen activators in polyacrylamide gels containing sodium dodecyl sulfate and copolymerized substrates. , 1980, Analytical biochemistry.

[53]  P. Pavasant,et al.  Molecular and cellular analysis of basement membrane invasion by human breast cancer cells in Matrigel-basedin vitro assays , 2005, Breast Cancer Research and Treatment.

[54]  P. Steeg,et al.  The invasive and metastatic properties of hormone-independent but hormone-responsive variants of MCF-7 human breast cancer cells , 2004, Clinical & Experimental Metastasis.

[55]  U. Moll,et al.  M(r) 92,000 type IV collagenase is increased in plasma of patients with colon cancer and breast cancer. , 1993, Cancer research.

[56]  P. Pavasant,et al.  Molecular and cellular analysis of basement membrane invasion by human breast cancer cells in Matrigel-based in vitro assays. , 1993, Breast cancer research and treatment.

[57]  G. Nicolson,et al.  Transfection of activated c-H-rasEJ/pSV2neo or pSV2neo genes into rat mammary cells: rapid stimulation of clonal diversification of spontaneous metastatic and cell-surface properties. , 1992, Oncogene.

[58]  N. Brünner,et al.  Assays for the study of human cancer cell invasion and metastasis , 1992 .

[59]  S. Parodi,et al.  Increased invasive, chemotactic and locomotive abilities of c-Ha-ras-transformed human breast epithelial cells. , 1991, Invasion & metastasis.

[60]  A. Eisen,et al.  Extracellular matrix metalloproteinases in tumor invasion and metastasis. , 1991, Cancer treatment and research.

[61]  K. Weber,et al.  Vimentin is preferentially expressed in human breast carcinomas with low estrogen receptor and high Ki-67 growth fraction. , 1990, The American journal of pathology.

[62]  E. Gelmann,et al.  Growth properties and tumorigenesis of MCF-7 cells transfected with isogenic mutants of rasH. , 1990, Cancer research.

[63]  M. Stampfer,et al.  Human mammary epithelial cells in culture: differentiation and transformation. , 1988, Cancer treatment and research.

[64]  S. Yuspa,et al.  Malignant conversion of murine squamous papilloma cell lines by transfection with the fos oncogene , 1988, Molecular carcinogenesis.

[65]  J. Thiery,et al.  Adhesion mechanisms in embryogenesis and in cancer invasion and metastasis. , 1988, Ciba Foundation symposium.

[66]  L. Liotta.  Tumor invasion and metastases--role of the extracellular matrix: Rhoads Memorial Award lecture. , 1986, Cancer research.

[67]  H. Strander.  Interferon treatment of human neoplasia. , 1986, Advances in cancer research.

[68]  V. Schirrmacher.  Cancer metastasis: experimental approaches, theoretical concepts, and impacts for treatment strategies. , 1985, Advances in cancer research.